Systemic lupus erythematosus secondary prevention: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
Secondary prevention strategies following systemic lupus erythematosus include using aspirin, ACE inhibitors, and statins to reduce atherosclerotic diseases, and using cancer screenings.
==Secondary Prevention==
==Secondary Prevention==
Early recognition of warning signs can help preventing the disease organ damages.
===Prevention of complications during pregnancy===
While most infants born to mothers who have SLE are healthy, pregnant mothers with SLE should remain under a doctor's care until delivery. Neonatal lupus is rare, but identification of mothers at highest risk for complications allows for prompt treatment before or after birth.  In addition, SLE can flare during pregnancy, and proper treatment can maintain the health of the mother longer. Women pregnant and known to have the antibodies for anti-Ro (SSA) or anti-La (SSB) should have echocardiograms during the 16th and 30th weeks of pregnancy to monitor the health of the heart and surrounding vasculature.
* Decrease atherosclerotic events in patients
* Decrease atherosclerotic events in patients
** Low doses of aspirin
** Low doses of aspirin
Line 17: Line 13:
** Statins
** Statins
* For prevention and/or early diagnosis of malignancies:
* For prevention and/or early diagnosis of malignancies:
** Regular age-related specific cancer screening recommended for the general population.
** Regular age-related specific cancer screening recommended for the general population


==References==
==References==

Revision as of 17:33, 4 July 2017

Systemic lupus erythematosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Systemic lupus erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Systemic lupus erythematosus secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Systemic lupus erythematosus secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Systemic lupus erythematosus secondary prevention

on Systemic lupus erythematosus secondary prevention

Systemic lupus erythematosus secondary prevention in the news

Blogs onSystemic lupus erythematosus secondary prevention

Directions to Hospitals Treating Systemic lupus erythematosus

Risk calculators and risk factors for Systemic lupus erythematosus secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Secondary prevention strategies following systemic lupus erythematosus include using aspirin, ACE inhibitors, and statins to reduce atherosclerotic diseases, and using cancer screenings.

Secondary Prevention

  • Decrease atherosclerotic events in patients
    • Low doses of aspirin
    • ACE inhibitors
    • Statins
  • For prevention and/or early diagnosis of malignancies:
    • Regular age-related specific cancer screening recommended for the general population

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Systemic_lupus_erythematosus_secondary_prevention&oldid=1322991"